250 related articles for article (PubMed ID: 27092498)
1. Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine.
Wang X; Wang N; Li H; Liu M; Cao F; Yu X; Zhang J; Tan Y; Xiang L; Feng Y
Int J Mol Sci; 2016 Apr; 17(4):577. PubMed ID: 27092498
[TBL] [Abstract][Full Text] [Related]
2. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma.
Itoh T; Hayashi Y; Kanamaru T; Morita Y; Suzuki S; Wang W; Zhou L; Rui JA; Yamamoto M; Kuroda Y; Itoh H
J Gastroenterol Hepatol; 2000 Apr; 15(4):422-30. PubMed ID: 10824888
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2.
Peng PL; Hsieh YS; Wang CJ; Hsu JL; Chou FP
Toxicol Appl Pharmacol; 2006 Jul; 214(1):8-15. PubMed ID: 16387334
[TBL] [Abstract][Full Text] [Related]
6. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
Tsang CM; Cheung KC; Cheung YC; Man K; Lui VW; Tsao SW; Feng Y
Biochim Biophys Acta; 2015 Mar; 1852(3):541-51. PubMed ID: 25496992
[TBL] [Abstract][Full Text] [Related]
7. Dioscorea nipponica Attenuates Migration and Invasion by Inhibition of Urokinase-Type Plasminogen Activator through Involving PI3K/Akt and Transcriptional Inhibition of NF-[Formula: see text]B and SP-1 in Hepatocellular Carcinoma.
Hsieh MJ; Yeh CB; Chiou HL; Hsieh MC; Yang SF
Am J Chin Med; 2016; 44(1):177-95. PubMed ID: 26916922
[TBL] [Abstract][Full Text] [Related]
8. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9.
Ho YT; Yang JS; Li TC; Lin JJ; Lin JG; Lai KC; Ma CY; Wood WG; Chung JG
Cancer Lett; 2009 Jul; 279(2):155-62. PubMed ID: 19251361
[TBL] [Abstract][Full Text] [Related]
9. Moscatilin Inhibits Metastatic Behavior of Human Hepatocellular Carcinoma Cells: A Crucial Role of uPA Suppression via Akt/NF-κB-Dependent Pathway.
Yu CL; Weng MS; Chen WC; Chien KT; Chi CW; Chung CH; Huang CW; Wang PC; Chen CC; Tsai AC; Liu SC; Wang SW
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805784
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy.
Wu JM; Sheng H; Saxena R; Skill NJ; Bhat-Nakshatri P; Yu M; Nakshatri H; Maluccio MA
Cancer Lett; 2009 Jun; 278(2):145-155. PubMed ID: 19303700
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanisms.
Jin Y; Liang ZY; Zhou WX; Zhou L
Hepatol Int; 2019 Mar; 13(2):180-189. PubMed ID: 30600477
[TBL] [Abstract][Full Text] [Related]
12. Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo.
Wei L; Lun Y; Zhou X; He S; Gao L; Liu Y; He Z; Li B; Wang C
Pharmacol Res; 2019 May; 143():73-85. PubMed ID: 30862605
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells.
Shin S; Kim MK; Jung W; Chong Y
Phytother Res; 2018 Oct; 32(10):2086-2096. PubMed ID: 30009577
[TBL] [Abstract][Full Text] [Related]
15. [Urokinase-type plasminogen activator (uPA), uPA receptor (uPA-R) and inhibitors (PA I -1) expression in hepatocellular carcinoma in relation to cancer invasion/metastasis and prognosis].
Zheng Q; Tang Z; Wu Z
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):57-9. PubMed ID: 10921061
[TBL] [Abstract][Full Text] [Related]
16. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.
Whitley BR; Palmieri D; Twerdi CD; Church FC
Exp Cell Res; 2004 Jun; 296(2):151-62. PubMed ID: 15149846
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis.
Fuessel S; Erdmann K; Taubert H; Lohse-Fischer A; Zastrow S; Meinhardt M; Bluemke K; Hofbauer L; Fornara P; Wullich B; Baretton G; Magdolen V; Wirth MP; Kotzsch M
BMC Cancer; 2014 Dec; 14():974. PubMed ID: 25519168
[TBL] [Abstract][Full Text] [Related]
18. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.
Fu ZG; Wang L; Cui HY; Peng JL; Wang SJ; Geng JJ; Liu JD; Feng F; Song F; Li L; Zhu P; Jiang JL; Chen ZN
Oncotarget; 2016 Feb; 7(8):9429-47. PubMed ID: 26882566
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6-shogaol and 6-gingerol.
Weng CJ; Chou CP; Ho CT; Yen GC
Mol Nutr Food Res; 2012 Aug; 56(8):1304-14. PubMed ID: 22714996
[TBL] [Abstract][Full Text] [Related]
20. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
